Healthcap.eu

Pulmonx Corporation Expands Leadership Team

WebPulmonx Corporation Expands Leadership Team. REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global …

Actived: 5 days ago

URL: https://www.healthcap.eu/media/pulmonx-corporation-expands-leadership-team/

HealthCap portfolio company Fusion Pharmaceuticals to be …

WebStockholm, 19 March 2024 – HealthCap announces the successful sale of one of its portfolio companies, Fusion Pharmaceuticals (“Fusion”), to AstraZeneca, for USD 2.4bn. This …

Category:  Health Go Health

HealthCap strengthens senior team

WebMårten Steen Promoted to Co-Managing Partner Expanded team with the appointment of several new partners Stockholm, 7 October 2021: HealthCap, a leading European life …

Category:  Health Go Health

Successful closing of a US$ 55M Series A financing

WebCopenhagen, Denmark and Boston, US – 22 July 2021 Hemab ApS (“Hemab”), a biotech company developing next generation therapeutics for serious …

Category:  Health Go Health

HelloBetter Raises €5 Million to Secure Road to Profitability

WebBerlin, Germany – September 21st, 2023 – HelloBetter, a digital health company specialising in evidence-based digital therapeutics, raises €5 million from HSBC Asset …

Category:  Health Go Health

Pretzel Therapeutics Launches With $72.5 Million Series A

WebCompany to leverage expertise in mitochondrial biology to advance novel treatments for both rare and common diseases Pretzel founded by leading academic …

Category:  Health Go Health

Doctrin raises €13 million to accelerate international expansion

Web21 JUNE 2021 Swedish health tech company Doctrin raises €13 million to fuel further expansion. The round is led by existing investors HealthCap, Swedbank Robur and …

Category:  Health Go Health

Adcendo ApS Announces Extension of Series A financing to

WebCopenhagen, Denmark, April 4th, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the …

Category:  Health Go Health

HealthCap Portfolio Company Hemab Therapeutics raises $135M …

WebHealthCap VIII portfolio company Hemab Therapeutics today announced the closing of an oversubscribed $135 million Series B financing. The round was led by …

Category:  Health Go Health

Precirix strengthens patent portfolio of its precision

WebBrussels, Belgium, 31 May 2022 – Precirix NV, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today provides an update on its …

Category:  Health Go Health

Hemab Therapeutics Announces First Patient Dosed in Phase 2 …

WebHMB-001 is a novel bispecific antibody designed to be the first prophylactic treatment for Glanzmann Thrombasthenia (GT) and other debilitating bleeding disorders …

Category:  Health Go Health

Hemab Therapeutics Presents Positive Phase 1 Results for HMB …

WebHMB-001 was well tolerated with no drug-related adverse or thromboembolic events; dose-dependent improvements in blood-clotting activity support the potential of …

Category:  Health Go Health